Karin Jirström

7PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 20, 2026
Tumor-Infiltrating Immune Cells Are More Abundant in Lung Metastases From Colorectal Cancer Than in Paired Primary Tumors and Their Prognostic Value Depends on Adjuvant Chemotherapy.

Danyil Kuznyecov, Christina Siesing, Halla Vidarsdottir

|Dec 14, 2025
Systemic and local decorin levels mirror the clinical course of pancreatic cancer.

Maja Svensson, Sophie Lehn, Hedda Jacobsen

|May 04, 2023
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution.

Bahar Rastegar, Natalie Andersson, Alexandra Petersson

|Aug 22, 2022
Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion.

Konstantinos S Papadakos, Sebastian Lundgren, Chrysostomi Gialeli

|Jun 09, 2021
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival.

Maria Christina Svensson, Albin Lindén, Jakob Nygaard

|Oct 12, 2020
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer.

Nina Andersson, Johan Ohlsson, Sara Wahlin

Pageof 2

Frequent Collaborators

2 joint publications

Karin Leandersson

1 joint publications

Maria Christina Svensson

1 joint publications

David Borg

1 joint publications

Konstantinos S Papadakos